Wednesday, 28 August 2019

Sun Pharma gains 5% as Sebi finds no merit in allegation of fraud

HDFC Securities has 'buy' rating on Sun Pharma with a 12-month target price of Rs 545 as the brokerage expects a recovery in the profitability (24 per cent margin) by FY21E.

from Markets https://ift.tt/2zuAICe

No comments:

Post a Comment

Goldprice dips Rs 10 to Rs 62,720, silver falls Rs 100 to Rs 74,900

The price of 22-carat gold also fell Rs 10 with the yellow metal selling at Rs 57,490 from Markets https://ift.tt/rpZGNwM